Cholecystokinin-B/gastrin receptor-targeting peptides for staging and therapy of medullary thyroid cancer and other cholecystokinin-B receptor-expressing malignancies-Reference-Cited by-同舟云学术

Cholecystokinin-B/gastrin receptor-targeting peptides for staging and therapy of medullary thyroid cancer and other cholecystokinin-B receptor-expressing malignancies

Published:2002-04 Issue:2 Volume:32 Page:97-109
ISSN:0001-2998
Container-title:Seminars in Nuclear Medicine
language:en
Short-container-title:Seminars in Nuclear Medicine

Author:

Behr Thomas M.,Béhé Martin P.

Publisher

Elsevier BV

Subject

Radiology, Nuclear Medicine and imaging

Reference66 articles.

1. High density of somatostatin receptors in pituitary tumors from acromegalic patients;Reubi;J Clin Endocrinol Metab,1984

2. Diagnostic applications of radiolabeled peptides in nuclear endocrinology;Behr;Q J Nucl Med,1999

3. Imaging tumors with peptide-based radioligands;Behr;Q J Nucl Med,2001

4. Radioimmunotherapy of solid tumors: A review “Of Mice and Men”;Behr;Hybridoma,1997

5. Regulatory peptide receptors as molecular targets for cancer diagnosis and therapy;Reubi;Q J Nucl Med,1997

Cited by 135 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Biodistribution and Radiation Dosimetry for 68Ga-DOTA-CCK-66, a Novel CCK2R-Targeting Compound for Imaging of Medullary Thyroid Cancer;Clinical Nuclear Medicine;2024-08-02

2. Peptide-Drug Conjugates: Design, Chemistry, and Drug Delivery System as a Novel Cancer Theranostic;ACS Pharmacology & Translational Science;2024-01-24

3. Endocrine system;Transpathology;2024

4. New horizon of radiopharmaceuticals in management of neuroendocrine tumors;Best Practice & Research Clinical Endocrinology & Metabolism;2023-09

5. Development of Highly Potent Clinical Candidates for Theranostic Applications against Cholecystokinin-2 Receptor Positive Cancers;Journal of Medicinal Chemistry;2023-07-26